1028 related articles for article (PubMed ID: 23609350)
1. Blood-brain barrier structure and function and the challenges for CNS drug delivery.
Abbott NJ
J Inherit Metab Dis; 2013 May; 36(3):437-49. PubMed ID: 23609350
[TBL] [Abstract][Full Text] [Related]
2. In-vitro blood-brain barrier models for drug screening and permeation studies: an overview.
Bagchi S; Chhibber T; Lahooti B; Verma A; Borse V; Jayant RD
Drug Des Devel Ther; 2019; 13():3591-3605. PubMed ID: 31695329
[TBL] [Abstract][Full Text] [Related]
3. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
4. From naturally-occurring neurotoxic agents to CNS shuttles for drug delivery.
Soddu E; Rassu G; Giunchedi P; Sarmento B; Gavini E
Eur J Pharm Sci; 2015 Jul; 74():63-76. PubMed ID: 25892455
[TBL] [Abstract][Full Text] [Related]
5. Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo.
Tietz SM; Engelhardt B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985749
[TBL] [Abstract][Full Text] [Related]
6. Targetability of the neurovascular unit in inflammatory diseases of the central nervous system.
Smith BC; Tinkey RA; Shaw BC; Williams JL
Immunol Rev; 2022 Oct; 311(1):39-49. PubMed ID: 35909222
[TBL] [Abstract][Full Text] [Related]
7. Development and Cell Biology of the Blood-Brain Barrier.
Langen UH; Ayloo S; Gu C
Annu Rev Cell Dev Biol; 2019 Oct; 35():591-613. PubMed ID: 31299172
[TBL] [Abstract][Full Text] [Related]
8. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
9. Advances in blood-brain barrier modeling in microphysiological systems highlight critical differences in opioid transport due to cortisol exposure.
Brown JA; Faley SL; Shi Y; Hillgren KM; Sawada GA; Baker TK; Wikswo JP; Lippmann ES
Fluids Barriers CNS; 2020 Jun; 17(1):38. PubMed ID: 32493346
[TBL] [Abstract][Full Text] [Related]
10. Integrating in Silico and in Vitro Approaches To Predict Drug Accessibility to the Central Nervous System.
Zhang YY; Liu H; Summerfield SG; Luscombe CN; Sahi J
Mol Pharm; 2016 May; 13(5):1540-50. PubMed ID: 27015243
[TBL] [Abstract][Full Text] [Related]
11. Overview of experimental models of the blood-brain barrier in CNS drug discovery.
Palmer AM; Alavijeh MS
Curr Protoc Pharmacol; 2013 Oct; 62():7.15.1-7.15.30. PubMed ID: 24510719
[TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier models: in vitro to in vivo translation in preclinical development of CNS-targeting biotherapeutics.
Stanimirovic DB; Bani-Yaghoub M; Perkins M; Haqqani AS
Expert Opin Drug Discov; 2015 Feb; 10(2):141-55. PubMed ID: 25388782
[TBL] [Abstract][Full Text] [Related]
13. New experimental models of the blood-brain barrier for CNS drug discovery.
Kaisar MA; Sajja RK; Prasad S; Abhyankar VV; Liles T; Cucullo L
Expert Opin Drug Discov; 2017 Jan; 12(1):89-103. PubMed ID: 27782770
[TBL] [Abstract][Full Text] [Related]
14. Targeting receptor-ligand chemistry for drug delivery across blood-brain barrier in brain diseases.
Anthony DP; Hegde M; Shetty SS; Rafic T; Mutalik S; Rao BSS
Life Sci; 2021 Jun; 274():119326. PubMed ID: 33711385
[TBL] [Abstract][Full Text] [Related]
15. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
Al-Ahmady ZS
Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
[TBL] [Abstract][Full Text] [Related]
16. Application of an in Vitro Blood-Brain Barrier Model in the Selection of Experimental Drug Candidates for the Treatment of Huntington's Disease.
Di Marco A; Gonzalez Paz O; Fini I; Vignone D; Cellucci A; Battista MR; Auciello G; Orsatti L; Zini M; Monteagudo E; Khetarpal V; Rose M; Dominguez C; Herbst T; Toledo-Sherman L; Summa V; Muñoz-Sanjuán I
Mol Pharm; 2019 May; 16(5):2069-2082. PubMed ID: 30916978
[TBL] [Abstract][Full Text] [Related]
17. Structure and Function of the Blood-Brain Barrier (BBB).
Benz F; Liebner S
Handb Exp Pharmacol; 2022; 273():3-31. PubMed ID: 33249527
[TBL] [Abstract][Full Text] [Related]
18. Mimicking brain tissue binding in an in vitro model of the blood-brain barrier illustrates differences between in vitro and in vivo methods for assessing the rate of brain penetration.
Heymans M; Sevin E; Gosselet F; Lundquist S; Culot M
Eur J Pharm Biopharm; 2018 Jun; 127():453-461. PubMed ID: 29602020
[TBL] [Abstract][Full Text] [Related]
19. Impact of transporters and enzymes from blood-cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake.
Wang Q; Zuo Z
Expert Opin Drug Metab Toxicol; 2018 Sep; 14(9):961-972. PubMed ID: 30118608
[TBL] [Abstract][Full Text] [Related]
20. The blood-brain barrier: bottleneck in brain drug development.
Pardridge WM
NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
